Differential tumor suppressor properties and transforming growth factor-β responsiveness of p57KIP2 in leukemia cells with aberrant p57KIP2 promoter DNA methylation
Authors:
Open Access
- 28 August 2006
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 26 (10) , 1439-1448
Abstract
To investigate if the tumor suppressor properties of p57KIP2 are dependent on its DNA methylation status, we studied the impact of several stress stimuli in leukemic cell lines with different p57KIP2 promoter DNA methylation levels. p57KIP2 reactivation was observed after stimulation with transforming growth factor-β, other cytokines, high-density culture or serum withdrawal in p57KIP2 promoter unmethylated cells but not in methylated cells. In these cells, p57KIP2 reactivation required the use of a hypomethylating agent or a histone deacetylase inhibitor. Overexpression of p57KIP2 in p57KIP2 promoter methylated leukemic cell lines resulted in cell growth arrest and the induction of apoptosis. In contrast, overexpression of p57KIP2 in partially methylated cells only resulted in a moderate inhibition of cell growth and had no impact on apoptosis. Transduction of unmethylated cells expressing high levels of p57KIP2 with p57KIP2 short hairpin RNA resulted in increased cell proliferation. These results suggest that the tumor suppressive properties of p57KIP2 in leukemia may depend on the intrinsic promoter DNA methylation status of the gene.Keywords
This publication has 27 references indexed in Scilit:
- Protein Expression of a Triad of Frequently Methylated Genes, p73, p57Kip2, and p15, Has Prognostic Value in Adult Acute Lymphocytic Leukemia Independently of Its Methylation StatusJournal of Clinical Oncology, 2005
- Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemiaBlood, 2004
- Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroupLeukemia, 2003
- Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemiaBlood, 2003
- Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemiaCancer, 2003
- Deletion of the Cancer-amplified Coactivator AIB3 Results in Defective Placentation and Embryonic LethalityJournal of Biological Chemistry, 2002
- Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumorsOncogene, 2002
- Methylation profiling in acute myeloid leukemiaBlood, 2001
- Human p57KIP2 defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumourOncogene, 1997
- Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cellsNature, 1987